Home » Interviews » INTERVIEW: ECO Animal Health Group plc Another Strong Performance
ECO Animal Health Group plc

INTERVIEW: ECO Animal Health Group plc Another Strong Performance

ECO Animal Health Group plc (LON: EAH) CEO Marc Loomes joins DirectorsTalk to discuss final results for the year ended 31 March 2019. Marc explains what has driven the growth, why expenditure is set to rise, the benefit of transferring it’s Aivlosin API manufacturing process to a new facility in China, the impact of African Swine Fever and the good growth territories.

ECO Animal Health based in London U.K. is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Its products for these growth markets promote well-being in animals and include the novel antimicrobial, Aivlosin®, as well as a range of generic therapeutic products.